Company / Net Debt per Share
Gossamer Bio, Inc. Net Debt per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.20
FY2024
5-year range
-$2.06 / -$0.20
FY2020-FY2024
Trend
+0.3%
vs FY2023
Sector context
#54 of 82
Health Care
What the data says
At $-0.20, Gossamer Bio, Inc.'s net debt per share ranks #29 of 82 in the Health Care sector. Net Debt per Share has increased for 4 consecutive years, from $-6.68 in FY2020 to $-0.20 in FY2024.
Based on SEC 10-K filings.
-0.20 in FY2024.
Increased from $-1.18 to $-0.20 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#29 of 82 in Health CareTop 34% of 82This company -$0.20 Sector average $13.70
▼
-101.5% below sector average
Key checks
Key Insights
- Gossamer Bio, Inc.'s net debt per share has grown for 4 consecutive years.
- In FY2024, net debt per share increased 0.3% year-over-year.
- Ranks #54 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$0.20 | +0.3% |
| FY2023 | -$0.21 | +82.7% |
| FY2022 | -$1.18 | +42.7% |
| FY2021 | -$2.06 | +69.1% |
| FY2020 | -$6.68 | -242.9% |
| FY2019 | -$1.95 | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026